Please use this identifier to cite or link to this item:
https://dspace.iiti.ac.in/handle/123456789/4014
Title: | The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: The hunt for new therapeutic targets |
Authors: | Baig, Mirza Saqib |
Keywords: | adenosine phosphate;complement component C3a;complement component C5a;gamma interferon;histamine;histamine H1 receptor;histamine H2 receptor;histamine H3 receptor;histamine H4 receptor;histamine receptor;interleukin 10;interleukin 12;interleukin 13;interleukin 2;interleukin 31;interleukin 4;interleukin 5;interleukin 6;interleukin 8;jnj 39758979;mitogen activated protein kinase;monocyte chemotactic protein 1;nerve growth factor;neurokinin 1 receptor;noradrenalin;protein kinase C;RANTES;transforming growth factor beta1;tumor necrosis factor;unindexed drug;vasoactive intestinal polypeptide;antihistaminic agent;cytokine;histamine;histamine H1 receptor antagonist;histamine H4 receptor;histamine receptor;allergy;antibody production;asthma;clinical trial (topic);cognitive defect;cytokine production;human;inflammation;mast cell;nonhuman;obesity;protein expression;protein phosphorylation;Short Survey;smooth muscle cell;stomach acid;upregulation;animal;blood brain barrier;hypersensitivity;immunology;inflammation;mast cell;metabolism;molecularly targeted therapy;Th1 cell;Animals;Blood-Brain Barrier;Cytokines;Histamine;Histamine Antagonists;Histamine H1 Antagonists;Humans;Hypersensitivity;Inflammation;Mast Cells;Molecular Targeted Therapy;Receptors, Histamine;Receptors, Histamine H4;Th1 Cells |
Issue Date: | 2018 |
Publisher: | Frontiers Media S.A. |
Citation: | Thangam, E. B., Jemima, E. A., Singh, H., Baig, M. S., Khan, M., Mathias, C. B., . . . Saluja, R. (2018). The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: The hunt for new therapeutic targets. Frontiers in Immunology, 9(AUG) doi:10.3389/fimmu.2018.01873 |
Abstract: | Histamine and its receptors (H1R-H4R) play a crucial and significant role in the development of various allergic diseases. Mast cells are multifunctional bone marrow-derived tissue-dwelling cells that are the major producer of histamine in the body. H1R are expressed in many cells, including mast cells, and are involved in Type 1 hypersensitivity reactions. H2R are involved in Th1 lymphocyte cytokine production. H3R are mainly involved in blood-brain barrier function. H4R are highly expressed on mast cells where their stimulation exacerbates histamine and cytokine generation. Both H1R and H4R have important roles in the progression and modulation of histamine-mediated allergic diseases. Antihistamines that target H1R alone are not entirely effective in the treatment of acute pruritus, atopic dermatitis, allergic asthma, and other allergic diseases. However, antagonists that target H4R have shown promising effects in preclinical and clinical studies in the treatment of several allergic diseases. In the present review, we examine the accumulating evidence suggesting novel therapeutic approaches that explore both H1R and H4R as therapeutic targets for histamine-mediated allergic diseases. © 2018 Thangam, Jemima, Singh, Baig, Khan, Mathias, Church and Saluja. |
URI: | https://doi.org/10.3389/fimmu.2018.01873 https://dspace.iiti.ac.in/handle/123456789/4014 |
ISSN: | 1664-3224 |
Type of Material: | Short Survey |
Appears in Collections: | Department of Biosciences and Biomedical Engineering |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Altmetric Badge: